Immunexpress Aims To Leverage Anti-Infection Incentives For Sepsis Diagnostic
This article was originally published in Start Up
Executive Summary
Immunexpress' SeptiCyte system is designed to directly quantify molecular markers of sepsis from patient blood samples and within a few hours detect the probability that a patient has sepsis, allowing for aggressive treatment, or if the test result is negative, preventing unnecessary antibiotics.